Orchestra BioMed Holdings, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
  • Orchestra BioMed Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.4M, a 15.8% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$57.7M, a 25.3% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$49.1M, a 46.2% decline from 2022.
  • Orchestra BioMed Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.6M, a 8773% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$49.1M -$15.5M -46.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$33.6M -$33.2M -8773% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$379K Jan 1, 2021 Dec 31, 2021 10-K 2023-01-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.